Eterna Therapeutics
$0.91
24
-$0.08-8.07% 今天
统计数据
当日最高
1
当日最低
0.86
52周最高
2.63
52周最低
0.84
成交量
92,592
平均成交量
25,915
市值
10.02M
市盈率
-
股息收益率
-
股息
-
即将到来
收益
13Nov预期
预期每股收益
N/A
实际每股收益
N/A
人们还关注
此列表基于关注ERNA的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
CRISPR Therapeutics
CRSP
市值4.06B
Editas Medicine
EDIT
市值308.46M
Intellia Therapeutics
NTLA
市值2.28B
Beam Therapeutics
BEAM
市值2.2B
Sangamo Therapeutics
SGMO
市值176.57M
Alnylam Pharmaceuticals
ALNY
市值33.72B
Ionis Pharmaceuticals
IONS
市值6.97B
Biomarin Pharmaceutical
BMRN
市值17.36B
Vertex Pharmaceuticals
VRTX
市值127.99B
Bluebird bio
BLUE
市值108.22M
关于
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Show more...
首席执行官
员工
8
国家
US
ISIN
US1140822099